Aspirin can help men live longer after prostate cancer treatment, a new study says.

Previous research has shown that aspirin may help in stopping the growth and spread of prostate cancer. The present study included approximately 6,000 men whose prostate cancer was treated with the help of radiation or surgery.

About 37 percent, or 2,220 men, were taking anticoagulants like warfarin, clopidogrel, enoxaparin, and/or aspirin. Researchers analyzed the chances of living longer in men who used these medications daily and those who did not.

The risk of dying within 10 years after prostate cancer treatment among men who used aspirin daily was lower than people who did not use the drug. The chances of a cancer relapse and the cancer spreading to bones were lower in the daily aspirin group.

"The results from this study suggest that aspirin prevents the growth of tumor cells in prostate cancer, especially in high-risk prostate cancer, for which we do not have a very good treatment currently. But we need to better understand the optimal use of aspirin before routinely recommending it to all prostate cancer patients,"said lead author Dr. Kevin Choe, assistant professor of radiation oncology at UT Southwestern in a news release. 

Medical Daily had earlier reported a study that said that low doses of aspirin reduce the risk of dying from cancers.

The study was published in the Journal of Clinical Oncology.